Novo Nordisk Prepares for CagriSema U.S. Launch in Early 2027
Novo Nordisk says it is advancing its pipeline and preparing for a U.S. launch of CagriSema in early 2027.
Novo Nordisk says it is advancing its pipeline and preparing for a U.S. launch of CagriSema in early 2027.